Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Promyelocytic, Acute

Explore clinical trials studying Leukemia, Promyelocytic, Acute. Study availability and eligibility vary by location and protocol.

87 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Promyelocytic, Acute trial results

Active, not recruiting

Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia

NCT03253848

Conditions
Acute Promyelocytic Leukemia With PML-RARA, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
View all 294 locations
View Trial Details
Active, not recruiting

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

NCT00003861

Conditions
Acute Lymphoblastic Leukemia, Acute Promyelocytic Leukemia, Hematologic Diseases, +13 more
Locations
  • Naval Medical Center - San Diego San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
View all 51 locations
View Trial Details
Completed

French Registry of First-line Treatment of Acute Promyelocytic Leukemia

NCT02938858

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Centre Hospitalier d'Aix en Provence Aix-en-Provence, France
  • Groupe Hospitalier SUD Amiens, France
  • Centre Hospitalier V. Dupouy Argenteuil, France
  • Hôpital Jean Minjoz Besançon, France
View all 27 locations
View Trial Details
Completed

Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia

NCT02688140

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • French-Belgian-Swiss APL study group All Participating Sites, France
  • AML-CG study group All Participating Sites, Germany
  • AML-SG study group All Participating Sites, Germany
  • OSHO study group All Participating Sites, Germany
View Trial Details
Completed

Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia

NCT00005962

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Cancer Center and Beckman Research Institute, City of Hope Duarte, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 65 locations
View Trial Details
Completed

S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia

NCT00492856

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Sutter Cancer Center at Roseville Medical Center Roseville, California, United States
  • Sutter Cancer Center Sacramento, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 210 locations
View Trial Details

Related conditions